Mavyretz Approved for Acute Hepatitis C; ALD Deaths Double; Entyvio in Pregnancy

(MedPage Today) -- The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus, AbbVie announced.
Compared with no treatment for chronic hepatitis...